Welcome to the investors section of Adocia  

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.


Latest Press Releases
2017/09/18Number of shares and voting rights of ADOCIA as of August 31, 2017
Read more
2017/07/19Adocia presents first half 2017 financial results
Read more

All Press releases

Next events

24-26 October 2017 CPhI Worldwide 2017, Frankfurt, Germany
See event

All events